Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
作者信息
Mamidi Rao N V S, Devineni Damayanthi, Sun Don, Yavin Yshai, Rosenthal Norman
机构信息
Janssen Research & Development, Raritan, New Jersey.
出版信息
Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455.
DOI:10.7326/L20-1455
PMID:33721528
Abstract
摘要
相似文献
1
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455.
2
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report.开始使用卡格列净治疗后出现的瑞舒伐他汀肌毒性：一例报告
Ann Intern Med. 2020 Oct 6;173(7):585-587. doi: 10.7326/L20-0549. Epub 2020 Aug 4.
3
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Ann Intern Med. 2021 Mar;174(3):431. doi: 10.7326/L20-1454.
4
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Ann Intern Med. 2021 Mar;174(3):432. doi: 10.7326/L20-1456.
5
Rosuvastatin and Colchicine combined myotoxicity: lessons to be learnt.瑞舒伐他汀与秋水仙碱联合肌毒性：值得吸取的教训。
CEN Case Rep. 2021 Nov;10(4):570-575. doi: 10.1007/s13730-021-00598-7. Epub 2021 May 24.
6
Rosuvastatin and risk of acute pancreatitis.
Int J Cardiol. 2015 Jul 1;190:293. doi: 10.1016/j.ijcard.2015.04.195. Epub 2015 Apr 24.
7
Authors' reply to rosuvastatin and risk of acute pancreatitis.
Int J Cardiol. 2015 Jul 15;191:270. doi: 10.1016/j.ijcard.2015.04.252. Epub 2015 May 1.
8
Drug Eruption Caused by Rosuvastatin.
J Investig Allergol Clin Immunol. 2017;27(2):140-141. doi: 10.18176/jiaci.0136.
9
Severe rosuvastatin accumulation with rhabdomyolysis due to drug interactions and low cardiac output syndrome.因药物相互作用和低心输出量综合征导致严重的瑞舒伐他汀蓄积并伴有横纹肌溶解。
Br J Clin Pharmacol. 2019 Jul;85(7):1616-1618. doi: 10.1111/bcp.13950. Epub 2019 May 3.
10
Drug Eruption to Rosuvastatin With Recurrence on Simvastatin: A Case Report.
J Cutan Med Surg. 2018 May/Jun;22(3):359-361. doi: 10.1177/1203475418756376. Epub 2018 Feb 3.
Zotero 插件